Sanuwave Health enters separation agreement with former CCO Nanci Gilmore

SANUWAVE Health, Inc.

Nanci Gilmore, former Chief Commercial Officer, was terminated without cause effective May 30, 2025.
Separation agreement provides lump sum cash of $97,916.70 (5 months salary) and pro-rated bonus of $14,790.81.
Stock options continue vesting through Jan 31, 2026: 31,111 options vest in three tranches (6,222; 6,223; 6,222).
Vested options remain exercisable at $14.20 per share until their original expiration dates.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.